Evidence map›Paper›PMID 36732110›Full record

ArticleSchizophrenia research2023

The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorder.

J M M Bayer, J Spark, M Krcmar, M Formica, K Gwyther, A Srivastava, A Selloni, M Cotter, J Hartmann, A Polari and 11 more

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 4 countries.

J M M BayerOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia. Electronic address: bayerj@student.unimelb.edu.au.
J SparkOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
M KrcmarOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
M FormicaOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
K GwytherOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
A SrivastavaIcahn School of Medicine at Mount Sinai, New York, NY, USA.
A SelloniIcahn School of Medicine at Mount Sinai, New York, NY, USA.
M CotterIcahn School of Medicine at Mount Sinai, New York, NY, USA.
J HartmannOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
A PolariOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Z R BilgramiEmory University, Atlanta, GA, USA.
C SaracIcahn School of Medicine at Mount Sinai, New York, NY, USA.
A LuIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Alison R YungOrygen, Parkville, Victoria, Australia; Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Australia; School of Health Sciences, University of Manchester, United Kingdom.
A McGowanIcahn School of Medicine at Mount Sinai, New York, NY, USA.
P McGorryOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
J L ShahMcGill Department of Psychiatry & Douglas Research Hospital, Montreal, Canada.
G A CecchiIBM TJ Watson Research Center, Yorktown Heights, NY, USA.
R MizrahiMcGill Department of Psychiatry & Douglas Research Hospital, Montreal, Canada.
B NelsonOrygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
C M CorcoranIcahn School of Medicine at Mount Sinai, New York, NY, USA; James J. Peters Veterans Administration, Bronx, NY, USA.
Icahn School of Medicine at Mount Sinai · USUniversity of Melbourne · AUOrygen · AUDouglas Mental Health University Institute · CAOrygen Youth Health · AUEmory University · US

Funding

Computational phenotyping of face expression in early psychosisR01MH132239 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHERYL MARY CORCORAN · 2023 to 2026
$2.8M
Using the RDoC Approach to Understand Thought Disorder: A Linguistic Corpus-Based ApproachR01MH115332 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CORCORAN, CHERYL MARY · 2018 to 2020
$1.6M
NIMH NIH HHS R01 MH115332NIMH NIH HHS R01 MH132239
6 · The paper itself

Abstract

aimPsychotic symptoms are typically measured using clinical ratings, but more objective and sensitive metrics are needed. Hence, we will assess thought disorder using the Research Domain Criteria (RDoC) heuristic for language production, and its recommended paradigm of "linguistic corpus-based analyses of language output". Positive thought disorder (e.g., tangentiality and derailment) can be assessed using word-embedding approaches that assess semantic coherence, whereas negative thought disorder (e.g., concreteness, poverty of speech) can be assessed using part-of-speech (POS) tagging to assess syntactic complexity. We aim to establish convergent validity of automated linguistic metrics with clinical ratings, assess normative demographic variance, determine cognitive and functional correlates, and replicate their predictive power for psychosis transition among at-risk youths.

methodsThis study will assess language production in 450 English-speaking individuals in Australia and Canada, who have recent onset psychosis, are at clinical high risk (CHR) for psychosis, or who are healthy volunteers, all well-characterized for cognition, function and symptoms. Speech will be elicited using open-ended interviews. Audio files will be transcribed and preprocessed for automated natural language processing (NLP) analyses of coherence and complexity. Data analyses include canonical correlation, multivariate linear regression with regularization, and machine-learning classification of group status and psychosis outcome.

conclusionsThis prospective study aims to characterize language disturbance across stages of psychosis using computational approaches, including psychometric properties, normative variance and clinical correlates, important for biomarker development. SPEAK will create a large archive of language data available to other investigators, a rich resource for the field.

Indexed as

Psychotic DisordersAdolescentHumansLanguageLinguisticsProspective StudiesSpeechLatent semantic analysisNatural language processingPart-of-speech-taggingPsychosisThought disorderUltra/clinical high risk

Identifiers

PMID36732110
PMCPMC10387495
OpenAlexW4318681796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.